These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 6775451

  • 1. Distribution of Pseudomonas aeruginosa serotypes in bacteriologic specimens and their aminoglycoside resistance.
    Ullmann U, Schmülling RM.
    Zentralbl Bakteriol A; 1980; 247(2):241-7. PubMed ID: 6775451
    [Abstract] [Full Text] [Related]

  • 2. [Serological typing of strains of Pseudomonas aeruginosa. II. Correlations between the O-serotype and sensitivity to 3 aminoglycosides (tobramycin, gentamicin and sisomicin)].
    Berti P, Maranini B, Mazzoni P.
    Ann Sclavo; 1980; 22(4):709-16. PubMed ID: 6787999
    [No Abstract] [Full Text] [Related]

  • 3. [The antimicrobial activity of amikacin in comparison with three other aminoglycoside-antibiotics (author's transl)].
    Jotzoff M.
    Med Klin; 1978 Jun 16; 73(24):914-7. PubMed ID: 661734
    [Abstract] [Full Text] [Related]

  • 4. In vitro susceptibility of gentamicin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to aminoglycoside antibiotics.
    Ramírez-Ronda CH, Nevárez M, Gutiérrez-Núñez JJ, Reyes Y.
    Bol Asoc Med P R; 1983 Jul 16; 75(7):305-7. PubMed ID: 6442865
    [No Abstract] [Full Text] [Related]

  • 5. Pseudomonas aeruginosa resistant to aminoglycosides: an assessment of the currently used methods of disk diffusion and dilution susceptibility.
    Ismaeel NA.
    Microbios; 1991 Jul 16; 66(268-269):197-204. PubMed ID: 1907714
    [Abstract] [Full Text] [Related]

  • 6. [Comparative study of the effect of sisomicin and other aminoglycosides on the causative agents of surgical infection].
    Navashin PS.
    Antibiotiki; 1982 Dec 16; 27(12):26-9. PubMed ID: 6819812
    [Abstract] [Full Text] [Related]

  • 7. Antimicrobial activity of netilmicin in comparison with gentamicin, sisomicin, tobramycin, and amikacin and their resistance patterns.
    Braveny I, Voeckl J, Machka K.
    Arzneimittelforschung; 1980 Dec 16; 30(3):491-5. PubMed ID: 7387761
    [Abstract] [Full Text] [Related]

  • 8. Serotyping, sites of isolation and resistance of Pseudomonas aeruginosa.
    Dette GA, Knothe H, Schäfer V, Pirlet-Berninger U.
    Microbiologica; 1988 Apr 16; 11(2):129-35. PubMed ID: 3136301
    [Abstract] [Full Text] [Related]

  • 9. Comparative evaluation of five aminoglycosides for treatment.
    Rosin H, Naumann P, Reintjens E, Köhler M.
    Int J Clin Pharmacol Biopharm; 1976 Apr 16; 13(3):157-67. PubMed ID: 820656
    [Abstract] [Full Text] [Related]

  • 10. Antibiotic susceptibility and serotyping of Pseudomonas aeruginosa strains isolated from surface waters, thermomineral waters and clinical specimens.
    Reali D, Rosati S.
    Zentralbl Hyg Umweltmed; 1994 Aug 16; 196(1):75-80. PubMed ID: 7802899
    [Abstract] [Full Text] [Related]

  • 11. [Serotypes and minimal inhibitory concentration of different antibiotics in strains of PS. aeruginosa isolated from urologic patients (author's transl)].
    Fernández H, Zaror L, Otth L, Gutiérrez A, Tejero A, Wilson MG.
    Rev Med Chil; 1978 Aug 16; 106(8):633-5. PubMed ID: 103157
    [No Abstract] [Full Text] [Related]

  • 12. Survey of aminoglycoside resistance patterns.
    Legakis NJ, Velonaki A, Velonakis EM, Lymberopoulou T.
    Chemioterapia; 1986 Jun 16; 5(3):185-90. PubMed ID: 3087636
    [Abstract] [Full Text] [Related]

  • 13. Nosocomial consequences of antibiotic usage.
    Giamarellou H, Touliatou K, Koratzanis G, Petrikkos G, Kanellakopoulou K, Lelekis M, Pagona A, Tsagarakis J, Symeonides J, Falagas M.
    Scand J Infect Dis Suppl; 1986 Jun 16; 49():182-8. PubMed ID: 3103210
    [Abstract] [Full Text] [Related]

  • 14. Comparison of the in vitro activity of new beta-lactams and aminoglycosides against clinical isolates of Pseudomonas aeruginosa.
    Patzer J, Gieburowska R, Dzierzanowska D.
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Oct 16; 253(1):110-20. PubMed ID: 6817544
    [Abstract] [Full Text] [Related]

  • 15. Transduction of amikacin, gentamicin and tobramycin resistance in Pseudomonas aeruginosa.
    Knothe H, Krcméry V, Mitsuhashi S.
    Zentralbl Bakteriol A; 1980 Mar 16; 246(3):373-8. PubMed ID: 6775445
    [Abstract] [Full Text] [Related]

  • 16. Gentamicin-resistant Pseudomonas aeruginosa and Serratia marcescens in a general hospital.
    Meyer RD, Lewis RP, Halter J, White M.
    Lancet; 1976 Mar 13; 1(7959):580-3. PubMed ID: 55850
    [Abstract] [Full Text] [Related]

  • 17. [Sensitivity of Pseudomonas aeruginosa to amikacin and to isepamicin in surgery and in intensive care].
    Vincent P, Vachée A, Izard D.
    Pathol Biol (Paris); 1997 Nov 13; 45(9):771-5. PubMed ID: 9538477
    [Abstract] [Full Text] [Related]

  • 18. Beta-lactam and aminoglycoside resistance rates and mechanisms among Pseudomonas aeruginosa in French general practice (community and private healthcare centres).
    Dubois V, Arpin C, Dupart V, Scavelli A, Coulange L, André C, Fischer I, Grobost F, Brochet JP, Lagrange I, Dutilh B, Jullin J, Noury P, Larribet G, Quentin C.
    J Antimicrob Chemother; 2008 Aug 13; 62(2):316-23. PubMed ID: 18467306
    [Abstract] [Full Text] [Related]

  • 19. [Evaluation of the "in vitro" activity of three aminoglycosides (gentamicin, tobramycin, and sisomicin) against "pseudomonas aeruginosa" strains (author's transl)].
    Berti P, Maranini B, Mazzoni P, Mori S.
    Ann Sclavo; 1978 Aug 13; 20(5):696-706. PubMed ID: 111631
    [No Abstract] [Full Text] [Related]

  • 20. Clinical, microbiologic, and epidemiologic characteristics of Pseudomonas aeruginosa infections in a University Hospital, Malatya, Turkey.
    Yetkin G, Otlu B, Cicek A, Kuzucu C, Durmaz R.
    Am J Infect Control; 2006 May 13; 34(4):188-92. PubMed ID: 16679175
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.